Healthcare Providers and Services
Company Overview of Intermountain Healthcare, Inc.
Intermountain Healthcare, Inc. owns and operates not-for-profit hospitals and clinics that serve communities in Utah and southern Idaho. It offers medical services in the areas of brain and spine care, cancer-care, heart care, pediatrics, women's health, and surgical services. Intermountain Healthcare, Inc. was founded in 1975 and is based in Salt Lake City, Utah.
36 South State Street
Salt Lake City, UT 84111
Founded in 1975
Key Executives for Intermountain Healthcare, Inc.
Chief Executive Officer, President and Trustee
Chief Financial Officer and Executive Vice President
Chief Operating Officer and Executive Vice President
Vice President, Trustee and Medical Group Chief Executive Officer
Trustee, Chief Executive Officer of Associated Food Stores and President of Associated Food Stores
Compensation as of Fiscal Year 2016.
Intermountain Healthcare, Inc. Key Developments
Intermountain Healthcare Announces New Collaboration with Asia Genomics
Sep 20 16
Intermountain Healthcare and Asia Genomics have announced a collaboration for Asia Genomics to distribute a test in Southeast Asia that delivers personalized medicine. Officials from both companies finalized an agreement where Asia Genomics now contracts with Intermountain Precision Genomics to offer ICG100 testing. Intermountain Precision Genomics ICG100 test is Next Generation Sequencing (NGS) that identifies mutations within a person's cancer to identify specific DNA targets for personalized drug treatments. Currently approved for late stage cancer patients who have failed a traditional treatment method, the ICG100 test offers new hope where traditional treatments fall short.
Intermountain Healthcare, Inc. Presents at UBS Genomics 2.0 Summit, Aug-11-2016 01:15 PM
Aug 7 16
Intermountain Healthcare, Inc. Presents at UBS Genomics 2.0 Summit, Aug-11-2016 01:15 PM. Venue: St. Regis Deer Valley, Park City, Utah, United States. Speakers: Nickolas Mark, Director.
Intermountain Health Care Announces Results from Atrial Fibrillation Study
May 31 16
Intermountain Healthcare, Inc. has announced results from a new study of more than 10,000 patients treated long term with the blood thinner, Warfarin, reveals higher rates of dementia for patients with atrial fibrillation versus patients without the common heart rhythm disorder. The study found that patients with atrial fibrillation who were treated long term with Warfarin had higher rates of dementia, Alzheimer's disease and vascular dementia compared to anticoagulated non-atrial fibrillation patients. The study was conducted through the Intermountain Healthcare Clinical Pharmacist Anticoagulation Service, which is part of the Intermountain Healthcare system based in Salt Lake City. Researchers enrolled a total of 10,537 patients with no history of dementia prior to the study.
Similar Private Companies By Industry
Recent Private Companies Transactions
The information and data displayed in this profile are created and managed by Capital IQ, a Standard & Poor's company. Bloomberg.com does not create
or control the content. For inquiries, please contact Capital IQ directly by clicking
Most Searched Private Companies
Sponsored Financial Commentaries